🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single arm, phase II trial. Safety will be monitored...
Status
Terminated
Location
Indiana University Health Hospital
Start Date
2017-10-13
Trial ID
NCT03213626
Treatments Being Tested
This study will compare the anti-tumor efficacy of apricoxib and gemcitabin...
Status
Completed
Location
Arizona Clinical Research Center
Start Date
2008-08
Trial ID
NCT00709826
Treatments Being Tested
It is well known that substantial interindividual variability of CYP3A4/1A2...
Status
Completed
Location
Cantonal Hospital St.Gallen
Start Date
2012-01
Trial ID
NCT01402089
Non-interventional, multi-country, multi-centre cohort study based on exist...
Status
Completed
Location
Royal Marsden Hospital
Start Date
2019-12-17
Trial ID
NCT04179890
The purpose of this study is to determine whether erlotinib is effective in...
Status
Withdrawn
Location
Northwestern University Feinberg School of Medicine Department of Dermatology
Start Date
TBD
Trial ID
NCT01006096
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. D...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2005-10
Trial ID
NCT00274833
Treatments Being Tested
This study is single center single arm prospective phase II study. In this ...
Status
Completed
Location
Samsung Medical Center
Start Date
2017-05-30
Trial ID
NCT03086538
Treatments Being Tested